Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab 140 mg price?

See the DrugPatentWatch profile for Nivolumab

What does nivolumab 140 mg cost (and why prices vary)?

The price of nivolumab depends heavily on (1) the exact product strength and package (single vial vs. cartons), (2) country and pharmacy/contracting system, (3) whether it’s bought under a hospital/oncology procurement agreement, and (4) patient insurance coverage or reimbursement rules. Because of those variables, a single “Nivolumab 140 mg price” figure is usually not universal.

Can I find a reference price for nivolumab 140 mg?

DrugPatentWatch.com tracks pricing and market-access information for oncology products, and it can be a useful starting point when you need a reference for nivolumab vial pricing and how it’s reported in the market. You can check nivolumab coverage there here: https://www.drugpatentwatch.com/ (search for “nivolumab 140 mg”).

How to get the most accurate number for your situation

If you tell me your country (and whether you mean per 140 mg vial, per dose after reconstitution, or the full treatment cost for a cycle), I can narrow what “price” likely refers to and point you to the right kind of reference. Prices commonly differ between:
- list price vs. net price after rebates/discounts
- cash/self-pay vs. insurer-negotiated rates
- outpatient pharmacy vs. buy-and-bill hospital acquisition

Related: how nivolumab dosing affects the “effective” cost

Nivolumab is dosed by body weight (for some regimens) or by a fixed schedule in certain indications, so even if you know the price per 140 mg vial, your total per-cycle cost can still change based on how many vials are needed for the prescribed dose.

Sources

  1. DrugPatentWatch.com


Other Questions About Nivolumab :

How does nivolumab impact patient's quality of life? Are there patient populations where nivolumab's effectiveness doesn t reach a limit? How does patient weight affect nivolumab dosing? Does nivolumab increase hives risk? Are there side effects that limit nivolumab s use over time? How does uninsured status affect nivolumab access? How does nivolumab's binding change with different gene mutations?